Clinical Trials

Showing trials with last updates posted in 2018.

NCT01275664 | TERMINATED | NA
4 participants

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2018-05-22
Start Date:
2011-06-30
Completion:
2014-05-31
Conditions
  • Nausea and Vomiting
  • Ovarian Brenner Tumor
  • Ovarian Clear Cell Cystadenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Mucinous Cystadenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Ovarian Serous Cystadenocarcinoma
  • Stage II Ovarian Cancer
  • Stage IIA Fallopian Tube Cancer
  • Stage IIA Ovarian Cancer
  • Stage IIB Fallopian Tube Cancer
  • Stage IIB Ovarian Cancer
  • Stage IIC Fallopian Tube Cancer
  • Stage IIC Ovarian Cancer
  • Stage IIIA Fallopian Tube Cancer
  • Stage IIIA Ovarian Cancer
  • Stage IIIA Primary Peritoneal Cancer
  • Stage IIIB Fallopian Tube Cancer
  • Stage IIIB Ovarian Cancer
  • Stage IIIB Primary Peritoneal Cancer
  • Stage IIIC Fallopian Tube Cancer
  • Stage IIIC Ovarian Cancer
  • Stage IIIC Primary Peritoneal Cancer
  • Stage IV Fallopian Tube Cancer
  • Stage IV Ovarian Cancer
  • Stage IV Primary Peritoneal Cancer
  • Undifferentiated Ovarian Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
NCT00899093 | TERMINATED
2500 participants

YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Study Type:
OBSERVATIONAL
Last Updated:
2018-05-22
Start Date:
2007-09-30
Completion:
2016-06-30
Conditions
  • Fallopian Tube Adenocarcinoma
  • Fallopian Tube Clear Cell Adenocarcinoma
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube Mucinous Adenocarcinoma
  • Fallopian Tube Serous Adenocarcinoma
  • Fallopian Tube Transitional Cell Carcinoma
  • Malignant Ovarian Brenner Tumor
  • Malignant Ovarian Clear Cell Tumor
  • Malignant Ovarian Endometrioid Tumor
  • Malignant Ovarian Mixed Epithelial Tumor
  • Malignant Ovarian Mucinous Tumor
  • Malignant Ovarian Neoplasm
  • Malignant Ovarian Serous Tumor
  • Malignant Ovarian Transitional Cell Tumor
  • Ovarian Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Stage IIIA Fallopian Tube Cancer
  • Stage IIIA Ovarian Cancer
  • Stage IIIA Primary Peritoneal Cancer
  • Stage IIIB Fallopian Tube Cancer
  • Stage IIIB Ovarian Cancer
  • Stage IIIB Primary Peritoneal Cancer
  • Stage IIIC Fallopian Tube Cancer
  • Stage IIIC Ovarian Cancer
  • Stage IIIC Primary Peritoneal Cancer
  • Stage IV Fallopian Tube Cancer
  • Stage IV Ovarian Cancer
  • Stage IV Primary Peritoneal Cancer
  • Undifferentiated Fallopian Tube Carcinoma
  • Undifferentiated Ovarian Carcinoma
Interventions
  • OTHER
No Results Yet
NCT00666588 | COMPLETED | PHASE2
52 participants

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2018-05-22
Start Date:
2008-04-30
Completion:
2012-12-31
Conditions
  • Adult Acute Monoblastic Leukemia (M5a)
  • Adult Acute Monocytic Leukemia (M5b)
  • Adult Acute Myeloblastic Leukemia With Maturation (M2)
  • Adult Acute Myeloblastic Leukemia Without Maturation (M1)
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myelomonocytic Leukemia (M4)
  • Childhood Acute Basophilic Leukemia
  • Childhood Acute Eosinophilic Leukemia
  • Childhood Acute Erythroleukemia (M6)
  • Childhood Acute Megakaryocytic Leukemia (M7)
  • Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)
  • Childhood Acute Monoblastic Leukemia (M5a)
  • Childhood Acute Monocytic Leukemia (M5b)
  • Childhood Acute Myeloblastic Leukemia With Maturation (M2)
  • Childhood Acute Myeloblastic Leukemia Without Maturation (M1)
  • Childhood Acute Myelomonocytic Leukemia (M4)
  • Recurrent Adult Acute Myeloid Leukemia
  • Recurrent Childhood Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
NCT03531554 | COMPLETED | NA
5 participants

Acute Nutritional Ketosis in VLCAD Deficiency

Study Type:
INTERVENTIONAL
Last Updated:
2018-05-21
Start Date:
2016-04-01
Completion:
2017-03-31
Conditions
  • VLCAD Deficiency
  • Fatty Acid Oxidation Defects
Interventions
  • DIETARY_SUPPLEMENT
  • BEHAVIORAL
  • PROCEDURE
  • DIAGNOSTIC_TEST
No Results Yet
NCT03530943 | UNKNOWN | NA
300 participants

Pet Partners for Promotion of Academic Life Skills

Study Type:
INTERVENTIONAL
Last Updated:
2018-05-21
Start Date:
2016-08-31
Completion:
2018-12-31
Conditions
  • Stress Prevention
  • Cortisol
  • Anxiety Disorders and Symptoms
  • Depression Disorders and Symptoms
  • Executive Functioning
  • Motivation and Learning
  • Momentary Emotion
  • Study Strategies
  • Perceived Stress
  • Animal Behavior
  • Animal Stress
  • Dyadic Interaction
  • Alpha-amylase
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page